Furthermore, pro-tumoral GAMs, which promote tumorigenesis, inhibit miR-340-5p expression in GBM cells by the upregulation of TGFβ-1, which increases HMGA-2 expression in GBM [51]. The gene discussed is HMGA2; the disease is glioblastoma.